A study from Fá et al. showed that extracellular application of different oTau species (recombinant human oTau, oTau extracted from AD human specimens, or naturally produced in mice overexpressing human Tau) could cause a rapid impairment in LTP and memory formation. Here, MAPT is linked to Alzheimer disease.